News

Filter

Current filters:

GlaxoSmithKline

1 to 9 of 3620 results

Sun Pharma to buy GSK’s opiates business in Australia

Sun Pharma to buy GSK’s opiates business in Australia

03-03-2015

UK pharma major GlaxoSmithKline and India’s largest drugmaker by sales, Sun Pharmaceutical Industries,…

AustraliaGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalSun Pharmaceutical Industries

Jeff Barrett named founding director of Centre for Therapeutic Target Validation with GSK and Wellcome

Jeff Barrett named founding director of Centre for Therapeutic Target Validation with GSK and Wellcome

02-03-2015

Jeffrey Barrett has been appointed the founding director for the Centre for Therapeutic Target Validation,…

BiotechnologyBoardroomCentre for Therapeutic Target ValidationGlaxoSmithKlineUK

GSK and Novartis complete major three-part transaction

02-03-2015

UK pharma major GlaxoSmithKline said this morning that its three-part transaction with Swiss peer Novartis…

GlaxoSmithKlineMergers & AcquisitionsNovartisOncologyPharmaceuticalVaccines

Lupin links with Celon Pharma for generic Advair Diskus

Lupin links with Celon Pharma for generic Advair Diskus

18-02-2015

Indian drug major Lupin has entered into a definitive agreement with Polish drugmaker Celon Pharma to…

Advair DiskusCanadaCelon PharmaGenericsGlaxoSmithKlineLicensingLupinMarkets & MarketingMexicoRespiratory and PulmonaryUSA

Vaccines a $25.5 billion business in 2014; report

Vaccines a $25.5 billion business in 2014; report

13-02-2015

Vaccines are a big business, and a growing business, says health care market researcher Kalorama Information,…

GlaxoSmithKlineMarkets & MarketingMerck & CoNovartisPfizerPharmaceuticalSanofiVaccines

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

10-02-2015

Following a less than flattering financial performance in 2014, UK pharma major GlaxoSmithKline is realigning…

FinancialGlaxoSmithKlineOncologyPharmaceuticalRespiratory and Pulmonary

GSK files for EU expanded indication for Revolade

GSK files for EU expanded indication for Revolade

06-02-2015

UK pharma major GlaxoSmithKline has filed a submission with the European Medicines Agency for a variation…

eltrombopagEuropeGlaxoSmithKlinePharmaceuticalRare diseasesRegulationRevolade

1 to 9 of 3620 results

COMPANY SPOTLIGHT

Menarini

Back to top